Search Results - "Wonodi, Ikwunga"

Refine Results
  1. 1

    Nicotine Effect on Prepulse Inhibition and Prepulse Facilitation in Schizophrenia Patients by ELLIOT HONG, L, WONODI, Ikwunga, LEWIS, Jada, THAKER, Gunvant K

    Published in Neuropsychopharmacology (New York, N.Y.) (01-08-2008)
    “…Acoustic prepulse inhibition (PPI) is considered an important biomarker in animal studies of psychosis and a number of psychiatric conditions. Nicotine has…”
    Get full text
    Journal Article
  2. 2

    Evidence of Missense Mutations on the Neuregulin 1 Gene Affecting Function of Prepulse Inhibition by Hong, L. Elliot, Wonodi, Ikwunga, Stine, O. Colin, Mitchell, Braxton D, Thaker, Gunvant K

    Published in Biological psychiatry (1969) (01-01-2008)
    “…Background Neuregulin 1 ( NRG1 ) is one of the leading candidate genes in schizophrenia. Rodents with NRG1 knock-out showed significantly impaired prepulse…”
    Get full text
    Journal Article
  3. 3

    Specific motion processing pathway deficit during eye tracking in schizophrenia: A performance-matched functional magnetic resonance imaging study by Hong, L. Elliot, Tagamets, Malle, Avila, Matthew, Wonodi, Ikwunga, Holcomb, Henry, Thaker, Gunvant K.

    Published in Biological psychiatry (1969) (01-04-2005)
    “…The neural mechanisms underlying smooth pursuit eye movement (SPEM) abnormalities in schizophrenia are not well understood. Previous evidence suggests that a…”
    Get full text
    Journal Article
  4. 4

    Independent Domains of Inhibitory Gating in Schizophrenia and the Effect of Stimulus Interval by Hong, L. Elliot, Summerfelt, Ann, Wonodi, Ikwunga, Adami, Helene, Buchanan, Robert W., Thaker, Gunvant K.

    Published in The American journal of psychiatry (01-01-2007)
    “…Objective: Patients with schizophrenia are known to have inhibitory gating deficits in the suppression of evoked potential P50 response to repeated stimuli and…”
    Get full text
    Journal Article
  5. 5

    Cortical Kynurenine Pathway Metabolism: A Novel Target for Cognitive Enhancement in Schizophrenia by WONODI, Ikwunga, SCHWARCZ, Robert

    Published in Schizophrenia bulletin (01-03-2010)
    “…The brain concentration of kynurenic acid (KYNA), a metabolite of the kynurenine pathway of tryptophan degradation and antagonist at both the glycine coagonist…”
    Get full text
    Journal Article
  6. 6

    Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia by Sathyasaikumar, Korrapati V., Stachowski, Erin K., Wonodi, Ikwunga, Roberts, Rosalinda C., Rassoulpour, Arash, McMahon, Robert P., Schwarcz, Robert

    Published in Schizophrenia bulletin (01-11-2011)
    “…The levels of kynurenic acid (KYNA), an astrocyte-derived metabolite of the branched kynurenine pathway (KP) of tryptophan degradation and antagonist of α7…”
    Get full text
    Journal Article
  7. 7

    Lack of association between COMT gene and deficit/nondeficit schizophrenia by Wonodi, Ikwunga, Mitchell, Braxton D, Stine, O Colin, Hong, L Elliot, Elliott, Amie, Kirkpatrick, Brian, Carpenter, Jr, William T, Thaker, Gunvant K, Buchanan, Robert W

    Published in Behavioral and brain functions (15-12-2006)
    “…The dopamine dysregulation hypothesis of schizophrenia posits that positive, negative and cognitive symptoms correlate with cortical/subcortical imbalances in…”
    Get full text
    Journal Article
  8. 8

    Association between Val108/158 met polymorphism of the COMT gene and schizophrenia by Wonodi, Ikwunga, Stine, O. Colin, Mitchell, Braxton D., Buchanan, Robert W., Thaker, Gunvant K.

    “…Schizophrenia is a complex disorder with a multifactorial polygenic inheritance with several genes conferring susceptibility at many genetic locations, each…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Influence of kynurenine 3-monooxygenase ( KMO ) gene polymorphism on cognitive function in schizophrenia by Wonodi, Ikwunga, McMahon, Robert P, Krishna, Nithin, Mitchell, Braxton D, Liu, Judy, Glassman, Matthew, Elliot Hong, L, Gold, James M

    Published in Schizophrenia research (01-12-2014)
    “…Abstract Background Cognitive deficits compromise quality of life and productivity for individuals with schizophrenia and have no effective treatments…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Clozapine in Reducing Aggression and Violence in Forensic Populations by Patchan, Kathleen, Vyas, Gopal, Hackman, Ann L., Mackowick, Marie, Richardson, Charles M., Love, Raymond C., Wonodi, Ikwunga, Sayer, MacKenzie A., Glassman, Matthew, Feldman, Stephanie, Kelly, Deanna L.

    Published in Psychiatric quarterly (01-03-2018)
    “…Popular media often portray people with a mental illness as being aggressive, violent, and incarcerated as a result of their behavior. Despite exaggeration in…”
    Get full text
    Journal Article
  14. 14

    Nicotine Enhances but Does Not Normalize Visual Sustained Attention and the Associated Brain Network in Schizophrenia by ELLIOT HONG, L, SCHROEDER, Matthew, ROSS, Thomas J, BUCHHOLZ, Brittany, JO SALMERON, Betty, WONODI, Ikwunga, THAKER, Gunvant K, STEIN, Elliot A

    Published in Schizophrenia bulletin (01-03-2011)
    “…Sustained attention abnormality in schizophrenia is usually refractory to available treatment. Nicotine can transiently improve sustained attention in…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Adjunctive Risperidone for Partially Responsive People with Schizophrenia Treated with Clozapine by WEINER, Elaine, CONLEY, Robert R, PATRICIA BALL, M, FELDMAN, Stephanie, GOLD, James M, KELLY, Deanna L, WONODI, Ikwunga, MCMAHON, Robert P, BUCHANAN, Robert W

    Published in Neuropsychopharmacology (New York, N.Y.) (01-10-2010)
    “…The large numbers of partial clozapine responders represent a major therapeutic challenge. Unfortunately, there are no clear data to support how best to treat…”
    Get full text
    Journal Article
  17. 17

    Dipyridamole monotherapy in schizophrenia: Pilot of a novel treatment approach by modulation of purinergic signaling by Wonodi, Ikwunga, Gopinath, Hirekatur V., Liu, Judy, Adami, Helene, Hong, L. Elliot, Allen-Emerson, Robert, McMahon, Robert P., Thaker, Gunvant K.

    Published in Psychopharmacologia (01-11-2011)
    “…Background Emerging data indicate the neuromodulator adenosine may play a role in the therapeutics of schizophrenia. Adenosine A 2A receptor stimulation exerts…”
    Get full text
    Journal Article
  18. 18

    A CHRNA5 allele related to nicotine addiction and schizophrenia by Hong, L. E., Yang, X., Wonodi, I., Hodgkinson, C. A., Goldman, D., Stine, O. C., Stein, E. S., Thaker, G. K.

    Published in Genes, brain and behavior (01-07-2011)
    “…Schizophrenia and nicotine addiction are both highly heritable phenotypes. Because individuals with schizophrenia have a higher rate of smoking than those in…”
    Get full text
    Journal Article
  19. 19

    Refining the Predictive Pursuit Endophenotype in Schizophrenia by Hong, L. Elliot, Turano, Kathleen A, O’Neill, Hugh, Hao, Lei, Wonodi, Ikwunga, McMahon, Robert P, Elliott, Amie, Thaker, Gunvant K

    Published in Biological psychiatry (1969) (01-03-2008)
    “…Background To utilize fully a schizophrenia endophenotype in gene search and subsequent neurobiological studies, it is critical that the precise underlying…”
    Get full text
    Journal Article
  20. 20

    Tardive dyskinesia in children treated with atypical antipsychotic medications by Wonodi, Ikwunga, Reeves, Gloria, Carmichael, Dana, Verovsky, Ilene, Avila, Matthew T., Elliott, Amie, Hong, L. Elliot, Adami, Helene M., Thaker, Gunvant K.

    Published in Movement disorders (15-09-2007)
    “…Recent years have witnessed increased antipsychotic treatment of children despite limited long‐term safety data in children. In this study, motor side effects…”
    Get full text
    Journal Article